Assessment of early response to imatinib 800 mg after 400 mg progression by F-18-fluorodeoxyglucose PET in patients with ... 18F-fluorodeoxyglucose (FDG) is the most commonly used PET radiopharmaceutical for oncology. FDG is a glucose analog in which ... An evaluation of [F-18]-fluorodeoxy-d-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as ... 18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. Hawkins, DS, et al. ...